Skip to main content
Cholangiocarcinoma
Comparison of the Clinical Features, Treatment Patterns, and Tumor Mutations of Patients with Intrahepatic and Extrahepatic CCA
Read More
Cholangiocarcinoma
Institutional Review Data Indicate That Actionable Genetic Testing and Personalized Medicine in Hepatobiliary and Pancreatic Cancers Is Rarely Applied
Read More
Cholangiocarcinoma
Patient-Derived Organoids for Personalized Drug Screening in Intrahepatic CCA
Read More
Cholangiocarcinoma
Drug Sensitivities Are Predicted with Tumor Organoid-Based Functional Analysis in Patients with Cholangiocarcinoma
Read More
Cholangiocarcinoma
Importance of PKN2 Signaling in the Development of Drug Resistance in Patients with CCA and FGFR2 Fusion
Read More
Cholangiocarcinoma
Correlation of Next-Generation Sequencing and PCR Analysis of ctDNA with Clinical Outcomes and Emerging Mutations Linked to Drug Resistance
Read More
Cholangiocarcinoma
Benefits of Lenvatinib plus Pembrolizumab in Solid Tumors, Including Biliary Tract Cancer
Read More
Cholangiocarcinoma
Reduction of Tumor Burden, Promotion of Hepatic Progenitor-Cell Differentiation, and Induction of Antitumor Immunity in Intrahepatic CCA with Ivosidenib, a Selective IDH1 Inhibitor
Read More
Cholangiocarcinoma
Neoadjuvant Chemoradiation and Orthotopic Liver Transplantation versus Definitive Chemoradiation in Unresectable CCA
Read More
Cholangiocarcinoma
NTRK Gene Fusions in Biliary Tract Cancers
Read More
Page 3 of 4
Results 21 - 30 of 34